TCM
CMD

Teza Capital Management’s Cantel Medical Corporation CMD Stock Holding History

Teza Capital Management’s Portfolio CMD Stock Details CMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-9,590
Closed -$424K – 671
2020
Q2 		$424K Buy
+9,590
New +$358K 0.09% 319
2019
Q4 		– Sell
-8,839
Closed -$661K – 787
2019
Q3 		$661K Buy
+8,839
New +$749K 0.17% 200

Other funds holding CMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LGP
Leonard Green & Partners Los Angeles, California $2.77B AUM 3.28% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Teza Capital Management's CMD Position: Q3 2020 in Review

Teza Capital Management sold out of Cantel Medical Corporation (CMD) in Q3 2020, closing a stake of 9,590 shares — an estimated $424K sold.

Teza Capital Management first reported a position in CMD in Q3 2019 and held it in 2 quarters. The position peaked at $661K in Q3 2019. 196 funds tracked by Wall St. Rank hold CMD as of Q3 2020.

  • Teza Capital Management reported no remaining Cantel Medical Corporation position as of Q3 2020 after selling out during the quarter.
  • Teza Capital Management sold 9,590 Cantel Medical Corporation shares in Q3 2020, an estimated $424K.
  • Teza Capital Management first reported a position in Cantel Medical Corporation in Q3 2019 and held it in 2 quarters.
  • Teza Capital Management's Cantel Medical Corporation position peaked at $661K in Q3 2019.
  • 196 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q3 2020.

Based on Teza Capital Management's 13F filing for Q3 2020, filed 12 Nov 2020.